182 related articles for article (PubMed ID: 7923098)
21. Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin.
Athanassiadou AM; Lazaris AC; Patsouris E; Tsipis A; Chelidonis G; Aroni K
Am J Dermatopathol; 2013 Jun; 35(4):425-31. PubMed ID: 23095338
[TBL] [Abstract][Full Text] [Related]
22. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
23. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay.
Kashiwazaki H; Tonoki H; Tada M; Chiba I; Shindoh M; Totsuka Y; Iggo R; Moriuchi T
Oncogene; 1997 Nov; 15(22):2667-74. PubMed ID: 9400993
[TBL] [Abstract][Full Text] [Related]
24. p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy.
Rugge M; Bovo D; Busatto G; Parenti AR; Fawzy S; Guido M; Ancona E; Ninfo V; Ruol A; Shiao YH
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):171-6. PubMed ID: 9138659
[TBL] [Abstract][Full Text] [Related]
25. Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis.
Ren ZP; Pontén F; Nistér M; Pontén J
Int J Cancer; 1996 Jun; 69(3):174-9. PubMed ID: 8682583
[TBL] [Abstract][Full Text] [Related]
26. p53 mutations in cutaneous lesions induced in the hairless mouse by a solar ultraviolet light simulator.
Queille S; Seite S; Tison S; Medaisko C; Drougard C; Fourtanier A; Sarasin A; Daya-Grosjean L
Mol Carcinog; 1998 Jul; 22(3):167-74. PubMed ID: 9688142
[TBL] [Abstract][Full Text] [Related]
27. Sunburn and p53 in the onset of skin cancer.
Ziegler A; Jonason AS; Leffell DJ; Simon JA; Sharma HW; Kimmelman J; Remington L; Jacks T; Brash DE
Nature; 1994 Dec 22-29; 372(6508):773-6. PubMed ID: 7997263
[TBL] [Abstract][Full Text] [Related]
28. Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis.
Einspahr JG; Alberts DS; Warneke JA; Bozzo P; Basye J; Grogan TM; Nelson MA; Bowden GT
Neoplasia; 1999 Nov; 1(5):468-75. PubMed ID: 10933063
[TBL] [Abstract][Full Text] [Related]
29. Mutant p53 expression in solar keratosis: an immunohistochemical study.
Sim CS; Slater S; McKee PH
J Cutan Pathol; 1992 Aug; 19(4):302-8. PubMed ID: 1430469
[TBL] [Abstract][Full Text] [Related]
30. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
[TBL] [Abstract][Full Text] [Related]
31. Alterations of p53 gene and Ha-ras gene are independent events in solar keratosis and squamous cell carcinoma.
Taguchi M; Tsuchida T; Ikeda S; Sekiya T
Pathol Int; 1998 Sep; 48(9):689-94. PubMed ID: 9778107
[TBL] [Abstract][Full Text] [Related]
32. Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas.
Spencer JM; Kahn SM; Jiang W; DeLeo VA; Weinstein IB
Arch Dermatol; 1995 Jul; 131(7):796-800. PubMed ID: 7611795
[TBL] [Abstract][Full Text] [Related]
33. [The role of P53 gene in the development of oral squamous cell carcinoma: study of P53 gene mutation by silver staining polymerase chain reaction-single strand conformation polymorphism].
Chen Q; Fu J; Yang G
Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov; 31(6):337-40. PubMed ID: 9592286
[TBL] [Abstract][Full Text] [Related]
34. Cyclin D and retinoblastoma gene product expression in actinic keratosis and cutaneous squamous cell carcinoma in relation to p53 expression.
Bito T; Ueda M; Ahmed NU; Nagano T; Ichihashi M
J Cutan Pathol; 1995 Oct; 22(5):427-34. PubMed ID: 8594075
[TBL] [Abstract][Full Text] [Related]
35. p53 gene mutations in squamous cell carcinoma occurring in scars: comparison with p53 protein immunoreactivity.
Sakatani S; Kusakabe H; Kiyokane K; Suzuki K
Am J Dermatopathol; 1998 Oct; 20(5):463-7. PubMed ID: 9790106
[TBL] [Abstract][Full Text] [Related]
36. Absence of p53 mutations in benign and pre-malignant male genital lesions with over-expressed p53 protein.
Castrén K; Vähäkangas K; Heikkinen E; Ranki A
Int J Cancer; 1998 Aug; 77(5):674-8. PubMed ID: 9688297
[TBL] [Abstract][Full Text] [Related]
37. Immunohistoselective sequencing (IHSS) of p53 tumor suppressor gene in human oesophageal precancerous lesions.
Shi ST; Feng B; Yang GY; Wang LD; Yang CS
Carcinogenesis; 1996 Oct; 17(10):2131-6. PubMed ID: 8895479
[TBL] [Abstract][Full Text] [Related]
38. p53 immunohistochemical expression in early posttransplant-associated malignant and premalignant cutaneous lesions.
Ferrándiz C; Fuente MJ; Fernández-Figueras MT; Bielsa I; Just M
Dermatol Surg; 1999 Feb; 25(2):97-101. PubMed ID: 10037511
[TBL] [Abstract][Full Text] [Related]
39. Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP.
Gomyo Y; Osaki M; Kaibara N; Ito H
Int J Cancer; 1996 May; 66(5):594-9. PubMed ID: 8647618
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical vs molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer.
Calzolari A; Chiarelli I; Bianchi S; Messerini L; Gallo O; Porfirio B; Mattiuz PL
Am J Clin Pathol; 1997 Jan; 107(1):7-11. PubMed ID: 8980360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
